Page last updated: 2024-10-29

ketanserin and Granulocytic Leukemia, Chronic

ketanserin has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sachithanandan, A1
Cuthbert, RJ1
Barros d'Sa, AA1

Other Studies

1 other study available for ketanserin and Granulocytic Leukemia, Chronic

ArticleYear
Interferon induced severe digital ischaemia in chronic myeloid leukaemia--successful treatment using ketanserin.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2001, Volume: 22, Issue:5

    Topics: Adult; Antineoplastic Agents; Female; Fingers; Humans; Interferons; Ischemia; Ketanserin; Leukemia,

2001